Aurobindo Pharma Price History
- Market cap
- ₹97,453 crore
- P/E
- 26.3
- P/B
- 2.57
- ROE
- 9.9%
- Dividend yield
- 1.20%
Aurobindo Pharma (AUROPHARMA) closed at ₹1,677.90 on 7 October 2026. It gained 22.00% over the past year, against +14.20% for the Nifty 50.
Aurobindo Pharma price chart
Daily closes, last 60 sessions since 8 Aug 2026.
Aurobindo Pharma returns vs Nifty 50
| Period | Aurobindo Pharma | Nifty 50 |
|---|---|---|
| 1D | -0.88% | +0.45% |
| 1W | +1.20% | +0.85% |
| 1M | +3.50% | +2.10% |
| 3M | +8.20% | +4.50% |
| 6M | +14.50% | +8.90% |
| 1Y | +22.00% | +14.20% |
| 3Y | +45.00% | +32.50% |
| 5Y | +85.00% | +65.00% |
52-week high and low
- Highest close in period shown
- ₹2,097.38
- Lowest close in period shown
- ₹1,258.43
Source: NSE end-of-day prices, adjusted for bonus issues and stock splits. Data as of 7 October 2026. How this data is compiled.
Aurobindo Pharma price history — frequently asked questions
What was the Aurobindo Pharma share price return over the last year?
Aurobindo Pharma returned +22.00% over the year to 7 October 2026, compared with +14.20% for the Nifty 50 over the same period.
Where does the Aurobindo Pharma price history come from?
The figures are daily closing prices from the NSE's end-of-day data, adjusted for bonus issues and stock splits so that earlier prices are comparable with today's. Monthly rows show the first open, highest high, lowest low and last close of each month.
Same Data For Peers
Trade Aurobindo Pharma With ATS
Track AUROPHARMA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.